Perimeter Medical Imaging AI (PINK) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
15 May, 2026Opening remarks and agenda
Meeting opened with a welcome, explanation of virtual procedures, and confirmation of recording consent.
Chair Suzanne Foster assumed the role of meeting chair and outlined participation rules for guests and shareholders.
Secretary and scrutineer roles were assigned, and the agenda and notice of meeting were confirmed as distributed.
Corporate governance
Quorum was confirmed as present, allowing the meeting to proceed with official business.
Voting procedures were explained, with electronic ballots open for all motions.
Financial performance review
Financial statements for the years ended December 31, 2024, and December 31, 2023, along with the auditor's report, were presented as received by shareholders.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Perimeter Medical Imaging AI
- FDA-approved AI imaging device reduces cancer reoperations and drives high-margin recurring revenue.PINK
Planet MicroCap Las Vegas 2026 - FDA-approved AI imaging platform Claire reduces repeat surgeries and targets scalable growth.PINK
Investor presentation - FDA approval of Claire OCT + AI and 14% recurring revenue growth signal rapid expansion ahead.PINK
Q1 2026 - Directors and auditor were elected, financials reviewed, and all motions passed by electronic vote.PINK
AGM 2024 - FDA-approved AI imaging device launches commercialization, targeting rapid market expansion.PINK
2026 Bloom Burton & Co. Healthcare Investor Conference - Record revenue growth and FDA approval for Claire OCT mark a pivotal year of transformation.PINK
Q4 2025 - AI-powered imaging platform drives better cancer surgery outcomes and scalable recurring revenue.PINK
Investor presentation - Revenue up 83% YoY, net loss down 35%, and pivotal B-Series OCT trial ahead of schedule.PINK
Q2 2024 - OCT imaging and AI reduce breast cancer reoperations, with FDA approval for B-Series targeted in 2025.PINK
Investor Update